Regarding the PR of 5-20-2013, the phrase "A highly collaborative effort with the FDA" makes me wonder who are the other collaborators along with PPHM? CSM, Feds, future partner, or more, or all of the above? Maybe we can chew on this thought while we wait for Tuesday? GLTA longs.
Jack Nicklaus had 18 Majors. Robert Garnick has 17. One more to tie. #18 will be particularly sweet. ;-) . . = = = = = = = = = In 10-2009, DR. ROBERT GARNICK joined Peregrine as Head/Regulatory ( http://tinyurl.com/yga7z4x ). In his 24 years at Genentech (1984-2008; from Feb’01–Oct’08 as Senior V.P. of Regulatory, Quality & Compliance), he was responsible for 17 new product approvals, including most of DNA’s top selling monoclonal antibody therapeutics such as Rituxan, Herceptin, Avastin, and Lucentis. He was responsible for all the regulated aspects of Genentech's business, including drug development, commercial production, and promotional & labeling compliance. As CEO Steve King said 6-29-11, “Rob is the ringmaster.” • See this 6-29-11 Minyanville article, “Peregrine Pharma's Secret Weapon [Robert Garnick]”http://tinyurl.com/9jtnano • Examples of Dr. Garnick's work at Genentech on Avastin (bevacizumab) approvals: http://tinyurl.com/yg7vtqa • All of Dr. Garnick's public comments (thru 5/2013) while at Peregrine: http://tinyurl.com/peq7xrt • On 7-16-12, RG said this about the ongoing Bavi+Doce randomized 2nd-Line NSCLC Ph.2B n=121 trial (which is going to double+ MOS vs. Doce ctl-arm): "I've seen a lot of Ph2 & Ph3 data, and this is as compelling Ph2 data as I've ever seen. So, I'm very comfortable proposing an [EOP2] meeting with the FDA for Q4'12."http://tinyurl.com/cs7spbz
Well I can thank Dr. Garnick for being involved in bringing Rituximab to market... I can happily say it worked for me!! Rituximab for liquid, Bavituximab for solid.
Market Data 
Markets 
AI
